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The observation by Lilly et al.  (1) that high leukemia mouse strains (AKR, 
C58,  RF,  and  C3H/Fg),  as  well  as  the  two  strains  utilized  by  Gross  to 
demonstrate a filterable virus agent from AKR mice, C3H/Bi,  and C57BR, are 
all  of the  H-2 k  haplotype,  suggested  that  a  relationship  existed  between 
susceptibility to  leukemogenesis and  the H-2 k  haplotype.  Further study of 
Gross virus-induced leukemia incidence in the cross C3H (H-2 k) x  C57BL (H- 
2 b) indicated quite clearly that a gene closely linked to the H-2 complex, Rgv- 
11  (resistance to Gross-virus-l), was one of two independently segregating loci 
sharing in the control of susceptibility to leukemogenesis (2). 
The importance of Rgv-1  in affecting susceptibility to  Gross  virus-induced 
leukemia was subsequently corroborated in studies with congenic strains of 
mice which differed from each other only with regard to the H-2 chromosomal 
segment. Thus, mice of the congenic C3H  (H-2 k) and C3H.SW  (H-2 b) strains 
differed markedly in their susceptibility to Gross virus, being highly susceptible 
and  highly resistant,  respectively (3). Several other  lines  of evidence also 
indicated an  effect of H-2  on  susceptibility to  viral  leukemia in  mice.  For 
example, Tennant and Snell (4) studying leukemogenesis  by the BALB-Tennant 
leukemia virus (BT/L) virus noted considerably higher levels of resistance in 
C57BL/10 (H-2 b) than in congenic B10.BR (H-2 k) mice. 
The first indication of the mechanism of action of Rgv-1  was obtained while 
studying H-2  effects on Friend virus-induced erythroleukemia (5). Susceptible 
mice required a tenfold lower Friend virus (FV) dose for splenomegaly  induction 
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and were much less prone to recovery from splenomegaly than resistant mice, 
indicating that  the H-2  difference of the hosts appeared to significantly alter 
the course rather than the onset of the disease. 
Studies with H-2  recombinant mice indicated that Rgv-1  maps within the K 
end  of  the  H-2  complex  (3),  comprising  the  K  and  I  regions.  The  clear 
demonstration  of  several  genes  that  regulate  the  level  of  immunological 
responses  (It  genes)  to  a  variety of natural  and  synthetic  antigens  mapping 
within the !  region of the H-2 complex (6,  7); the close or identical mapping of 
Rgv-1  with the I  region; and the indication from FV disease studies that the H- 
2  effect  may  influence  a  late  event  in  the  disease,  namely  recovery  from 
splenomegaly (5),  suggested a  possible identity between Rgv-1  and Ir  gene(s) 
(7, 8). Thus, H-2-1inked resistance to virus-induced leukemogenesis may result 
from a  stronger immunological response to a  given virus-induced antigen. 
One indication that this hypothesis might be corrrect is the finding of Aoki 
et  al.  (9)  in  studies  with  Gross  virus  that  a  significant  number  of mice 
homozygous or heterozygous for the 1-1-2 b haplotype showed detectable levels of 
anti-Gross  virus  antibodies,  but  no  H-2 k  homozygotes produced  measurable 
antibodies.  In experiments by Sato et al.  (10),  several leukemias derived from 
BALB/c mice were rejected by hybrids of BALB/c with other inbred  strains, 
contrary  to the usual  rules  of transplantation.  Genetic  studies  on a  series of 
hybrids established that  responsiveness to these tumors was linked to the K 
end of  H-2, the same location as Rgv-1  and the majority ofH-2-1inked Ir genes. 
Furthermore,  animals  resistant  to the tumor had higher  titers of antibody to 
Gross-specific antigens than susceptible animals. 
In  addition,  genetic  control  of susceptibility to  infection  with  lymphocytic 
choriomeningitis  virus (LCM) has been demonstrated by Oldstone et al.  (11). 
Susceptibility to LCM, a dominant trait,  is associated with the H-2 q haplotype, 
whereas resistance  is found with the H-2 k  genotype.  Because the pathogenic 
consequences of LCM infection result from the immune response,  it has been 
proposed  that  Ir  genes  may  be  responsible  for H-2-1inked  susceptibility  or 
resistance to LCM infection (12). 
The studies presented here were undertaken to test the hypothesis that H-2- 
linked genetic control of resistance to leukemogenesis results from a heightened 
immune  response  in  the  resistant  animal.  In  brief,  AKR mice  were crossed 
with animals of various H-2 congenic strains on the C3H and C57BL/10 genetic 
backgrounds, and the hybrid mice injected with tumor cells from an established, 
tissue  culture-adapted  AKR thymoma.  The  resulting  cell-mediated  immune 
response of such hybrids was studied. The results demonstrate that the ability 
to generate  a  primary or secondary cell-mediated response to an AKR tumor 
cell antigenic determinant is under H.2  linked control and the locus determin- 
ing cell-mediated lympholysis (CML) responsiveness maps in the I-J subregion. 
Materials  and  Methods 
Cell  Lines  Used.  BW5147,  an  AKR-derived  cell  line  adapted  to  culture  in  1972  from  a 
spontaneous cell tumor originating at The Jackson Laboratory, Bar Harbor, Maine in 1954  (13), 
and EL-4,  a  C57BL/6-derived cell line adapted in  1970  from acute  (benzo  [a-] pyrene-induced 
leukemia; reference 13),  were obtained from the Salk Institute. AKR mouse embryo fibroblast D.  MERUELO,  B.  DEAK,  AND  H.  O.  McDEVITT 
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Strain  H-2 haplotype 
Haplotype origin of region H-2 
K  A  B  J  E  C  S  G  D 
AKR  1-1-2 k  k  k  k  k  k  k  k  k  k 
C3H.SW  H-2 b  b  b  b  b  b  b  b  b  b 
C3H.Q  H-2 q  q  q  q  q  q  q  q  q  q 
C3H  H-2 ~'*  k  k  k  k  k  k  k  k  k 
CKB  H-2 k*  k  k  k  k  k  k  k  k  k 
B10.G  H-2 q  q  q  q  q  q  q  q  q  q 
B10.S  H-28  s  s  s  s  s  s  s  s  s 
C57BL/10  1-1-2 b  b  b  b  b  b  b  b  b  b 
B10.BR  H-2 k  k  k  k  k  k  ~-k  k  k  k 
B10.A  H-2 a  k  k  k  k  k  I  d  d  d  d 
B10.A (1R)  H-2 ~1  k  k  k  k  k  d  d  d  ]  b 
B10.A (2R)  H-2 ~2  k  k  k  k  k  d  d  d  [  b 
B10.A (3R)  H-2 ~  b  b  b  b  I  k  d  d  d  d 
B10.A (4R)  1-1-2 ~4  k  k  {  b  b  b  b  b  b  b 
B10.A (SR)  1-1-2 '5  b  b  b  [  k  k  d  d  d  d 
* CKB and C3H mice differ in their allotype. 
Vertical bar indicates crossover position. 
were isolated in our laboratory from a  14-day pregnant AKR mouse and established as a 3T3 cell 
line by the methodology described by Paul (14). 
Studies by ShrSder, personal communication, have shown that the BW5147 cell line had 43, 
sometimes 44 or 86,  chromosomes,  and most of them could be identified as part of the normal 
mouse complement. The majority of the cells have identical karyotypes, although minor variation 
or tetraploidy is found in a  few.  In general, one pair of each chromosome is represented, except 
for chromosomes 3,  18, and X. Only one normal chromosome number 3 is found, the other being 
part of a  translocation, and both chromosomes 18 are present in an isochromosome 18.  The cell 
line has only one X chromosome. By banding analysis, the line appears to lack a  Y chromosome 
and thus is phenotypically female. A  few marker chromosomes of unidentifiable origin are also 
present.  Detailed  studies  of the  translocation  involving  one  of  the  chromosomes  number  3 
indicated that the other chromosome is number 17 with a  terminal deletion. Thus, the BW5147 
cell line is trisemic for most of chromosome 17. 
BW5147 is 0-AKR  ÷ (13), TL- (15), H-2 ~+ (13), and PHA sensitive (13). EL-4 cells are G +, H-2  ~+, 
e-C3H ÷, TL-,  Ly-l.2 +, surface Ig-, cortisone resistant, and PHA sensitive (13). 
Mice.  AKR/J mice were purchased from The Jackson Laboratory,  Bar Harbor,  Maine.  All 
other mouse strains were bred and maintained in our own colonies. 
H-2  Typing  of Backcross  Progeny.  National  Institutes of Health  contract  antiserum  D-17 
([D1.C  ×  AKR.M]F1 anti-DBA.1 [anti-H-2Kq]) and an (A.TL  ×  B10.A[5R]FI anti-B10.A [anti-H- 
2Kk])  antiserum  raised  in  our  laboratory  were  used  to H-2  type  (AKR  ×  B10.G)F~  ×  AKR 
progeny by the hemagglutination procedure (16). 
Preparation  of Effector Cells.  Animals were killed by cervical dislocation and their spleen 
and mesenteric lymph nodes removed by sterile technique in phosphate-buffered saline (PBS) + 
5%  fetal  calf  serum  (FCS),  and  single  cell  suspensions  prepared  with  gentle  teasing  and 
pipetting.  Peritoneal exudate cells were obtained by flushing the peritoneal cavity with sterile 
PBS. 
Preparation of Target Cells.  BW5147, EL-4,  or AKR mouse embryo fibroblast cells (viability 
greater  than  90%)  were  incubated  at  a  concentration  of  10  ×  106/ml  in  Dulbecco's  minimal 
essential medium  (MEM)-10% FCS with 1 mCi/ml of slCr for 1 h  at 37°C  (in a  CO2 incubator). 
The reaction was terminated by adding cold PBS +  5% FCS.  Cells were spun and washed three 
times or until the amount of 6~Cr remaining in the supernatant fluid was  <5% of the amount 
remaining in the cell pellet. 1370  GENETIC  CONTROL  OF  CELL-MEDIATED  RESPONSIVENESS 
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FIG.  1.  10  x  105 AKR tumor cells were inoculated into  (AKR  x  B10.BR)F1  hybrids at 
various intervals. At the conclusion of the experiment all animals were sacrificed and cell 
suspensions shown were tested in a  12-h cytotoxic test against 5~Cr-labeled AKR tumor 
cells as described in Materials and Methods. The assay was performed with three different 
effector to target cell ratios: (A) 600:1;  (B) 60:1,  and (C) 15:1. 
Assay of CML.  Effector cells were incubated with target cells in a  total volume of 0.3 ml of 
Dulbecco's MEM +  10% FCS at 37°C in a CO2 incubator for 12-16 h in a microwell dish (IS-MRC- 
96 from Flow  Laboratories,  Inc.,  Rockville,  Md.).  The microwell  dish was then centrifuged at 
1,000 rpm for 10 min and 0.1 ml of the supernate was removed and counted, in a Searle Analytic 
(Nuclear Chicago) gamma counter  (1185 series; Searle Analytic Inc.,  Des Plaines, Ill.).  Unless 
otherwise indicated, the results are expressed as percent specific lysis, which is calculated by the 
formula: 
experimental 5~Cr release-spentaneous 5~ Cr release 
% specific lysis =  maximum 5~Cr release-spontaneous 5~Cr release  ×  100 
where  maximum  release  is defined  by the  51Cr cpm obtained after freezing and thawing the 
labeled  target  cells  six  times;  spontaneous  release  is  leakage  of ~lCr  cpm  from  target  cells 
unexposed to  effector cells,  i.e.,  target cells incubated alone in media for the duration of the 
experiment (spontaneous release usually was 20 -+ 5%). 
Results 
Kinetics  and  Specificity  of the  Cell-Mediated  Response  to  AKR  Tumor 
Cells.  F1  mice produced by mating AKR/J  with various C3H  and B10 H-2 
cogenic strains were inoculated with 107 AKR tumor cells (BW5147) at various 
intervals, sacrificed at the conclusion of the experiment, and cell suspensions 
of spleen, mesenteric lymph node (LNC),  and peritoneal exudate (PEC) were 
prepared to test for the presence of cytotoxic killer cells on ~lCr-labeled AKR 
tumor cells. 
Results shown in Fig.  1 indicate that (a) maximum cytotoxicity is obtained 
from LNC and PEC 10 to 15 days after injection of BW5147 tumor cells, and (b) 
no cytotoxic or killer cells are apparent in any of the spleen cell populations 
tested.  Subsequent experiments, designed to test the target specificity of the 
response, indicated that PEC effectors are not always specific for AKR tumor D.  MERUELO,  B.  DEAK,  AND  H.  O.  McDEVITT  1371 
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FIG.  2.  Cell-mediated responses of 12  x  10  e mesenteric lymph node cells from animals 
immunized 10 days earlier with the indicated number of tumor cells. 34  ×  103 slCr-labelod 
AKR tumor cells were used as targets for each assay. The lysis represents the percent of 
label released after 16 h of incubation with effector cells. 
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cells, but also lyse other cell types, such as EL-4 tumor cells and normal AKR 
embryo fibroblasts. The target specificity of LNC was always strictly restricted 
to the AKR tumor cells used in the in vivo challenge. All subsequent work was 
carried out with the more selective LNC effector population. 
Genetic Regulation of CML Responsiveness.  A comparison made of the cell- 
mediated immune responsiveness to BW5147 of different F1 hybrid cells revealed 
apparent genetic regulation. Fig. 2 shows the response of four such hybrids; 
(CKB  ×  AKR)F1  and  (B10.BR  ×  AKR)F1  both respond vigorously and are 
homozygous at H-2  (H-2klk).  The difference in their non-H-2 genetic composi- 
tion does not affect the response. On the other hand,  (C3H.Q  ×  AKR)F1 and 
(B10.G  ×  AKR)F, both identical in their H-2  genotypes, namely H-2 qlk  (but, 
again,  different in  their  non-H-2  genetic make up),  fail  to  respond.  These 
results indicate that the H-2 qlk genotype results in nonresponsiveness, whereas 
the H-2 ~Ik  genotype results  in  responsiveness,  independent of the  non-H-2 
genetic background of the F1 strains used. 
The observed differences in responsiveness could be attributed to a genetically 
controlled difference in immune responsiveness. Another explanation, however, 
involves the  possibility of differential growth of the  injected tumor cells in 
different F~ hybrids. The more rapid growth in one F~ strain might serve as a 
stronger antigenic stimulus, or alternatively, rapid invasiveness by the tumor 
cells might lead to greater impairment of the immunological apparatus and 
capacity to respond. To study this possibility, irradiated (3,000 rads) BW5147 
cells were inoculated into F1 hybrid mice of the H-2 k~  and H-2 q~k genotypes. 
When cells are  exposed to 3,000  rads, they remain antigenically intact,  and 1372  GENETIC  CONTROL  OF  CELL-MEDIATED  RESPONSIVENESS 
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FIa.  3.  Conditions were as described for Fig. 2, except that tumor cells inoculated were 
exposed to 3,000 rads in a Cessium irradiator before injection. 
viable by the criterion of exclusion of trypan blue, but are unable to multiply 
and grow. As shown in Fig. 3, when irradiated cells were inoculated into these 
same hybrids, H-2 k~k animals responded and H-2 qlk animals failed to respond, 
indicating that the results previously obtained could not be ascribed to differ- 
ential growth rates of the AKR cells in the different hybrids. 
H-2 qlk animals remained unresponsive in a secondary CML response (irradi- 
ated tumor cells were injected, followed 25  days later by inoculation of live 
cells),  whereas H-2 klk  F1  mice mounted a  vigorous secondary response  (data 
not shown). 
Formal proof of linkage between cell-mediated responsiveness and H-2  was 
obtained by carrying out a backcross segregation analysis.  (B10.G  ×  AKR)F1 
mice (H-2 qlk) were backcrossed to AKR (H-2 kfk) mice. The predicted outcome 
of such a backcross is 50% H-2 ~fk  animals, all of which should be responsive, 
and 50%  H-2 q~k  mice,  all  of which should be  unresponsive.  Out  of 20  such 
animals tested (Fig. 4), 9 were H-2 q~k and completely unresponsive and 11 were 
H-2 k~k, 8 of which demonstrated a normal cytotoxic response. These results are 
in  good  agreement with  the  predicted  outcome  for  H-2  linkage  of  CML 
responsiveness. The reason why 3 out of 11 H-2 k/k animals failed to respond is 
unclear.  Experimental error  at  some point  might  have  occurred, but  it  is 
equally as likely that biological variation, or additional genetic interactions, 
may be responsible for the three unresponsive H-2 klk. 
Strain  Distribution  Survey  of F1  Nonresponsive  Trait.  The above results 
illustrate that homozygous  H-2 k~k animals are able to respond, whereas hetero- 
zygous H-2 q~k animals are not, a finding which suggests that responsiveness is 
regulated either by (a) a recessive trait or (b) a dominant suppressor gene(s) 
which causes nonresponsiveness. This is an unusual finding in that most H-2- 
linked Ir  genes  defined to  date  have  shown  dominant  responsiveness  (6); D.  MERUELO,  B.  DEAK,  AND  H.  O.  McDEVITT  1373 
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FIG. 4.  Cell-mediated  responses of (BI0.G x AKR)F,  x AKR  mice inoculated 14 days 
earlier  with 5 x 106 AKR  tumor cells  as a function of  increasing numbers of  lymph node 
cells  (shown) to a constant number of  s'Cr-labeled  AKR  target cells  (90,000).  Mice were  H- 
2 typed by hemagglutination assay. 11 mice were  H-2  ~r~ (O  O) and 9 mice were  H-2  qlk 
(¢  i). Incubation time of  CML  assay was 14 h. 
however, several workers have recently demonstrated the  existence of H-2 
linked, dominant immune suppression gene(s) (17, 18). 
It  is,  therefore,  important  to  determine whether  any H-2  heterozygous 
animal is capable of a cell-mediated cytotoxic response to AKR tumor cells, or 
whether  only  H-2 k~k  homozygous  mice  are  able  to  respond.  Should  some 
heterozygous mice be found to respond, the notion of suppression, in contrast to 
recessive responsiveness, would be supported. Fig. 5 shows the results obtained 
when other H-2  heterozygous animals were tested. H-2 blk  F, mice ([C.SW  × 
AKR]F,) failed to respond (as did H-2 qlk  F,  [B10.G  ×  AKR]F, or  [C3H.Q  × 
AKR]F,), but H-2  "Ik  F,  ([BI0.S  x  AKR]F,) mice generated  a  cell-mediated 
cytotoxic response comparable to that of homozygous  H-2  klk mice ([BI0.BR x 
AKR]F, or  [C3H x  AKR]F,). The fact that H-2  "Ik  F,  respond suggests  that 
responsiveness is not a recessive trait. However, it could be argued that the H- 
2 s and H-2  k haplotypes share  the same allele as the gene(s) responsible for 
generation  of a  cell-mediated  cytotoxic response,  and  an  H-2  sIk  F,  animal 
responds because it is homozygous  for the recessive allele at this locus. 1374  GENETIC  CONTROL  OF  CELL-MEDIATED  RESPONSIVENESS 
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FIG.  5.  Cell-mediated cytotoxic response of 107 lymph node cells to 50  x  103 51Cr-]abeled 
AKR tumor cells. Animals were injected 10  days earlier with the indicated number of 
tumor cells. Effecter and target cells were incubated for a  total of 12 h. 
Mapping  of CML Responsiveness  to  the I-J Subregion.  As seen in Fig.  5, 
(C.SW  ×  AKR)F1 mice  (H-2 bfk) do not make a  cytotoxic response to the AKR 
tumor  cells,  at  least  under  the  experimental  conditions  used.  Further  tests 
with  H-2 btk  mice  have  shown  that  nonresponsiveness  in  this  hybrid  is  not 
absolute. H-2 k/b  mice can respond if injected with a  sufficiently large dose of 
tumor cells and if a sufficiently high ratio of lymph node effector to target AKR 
cells is tested. The finding that H-2 k/b mice are low responders in terms of cell- 
mediated immunity to AKR tumor cells is a  fortunate one, because it allows 
more precise genetic mapping within the H-2  complex of the locus responsible 
for  nonresponsiveness.  A  substantial  number  of available  H-2  recombinant 
mice have been derived from a crossover between the H-2 ~ and H-2" haplotypes. 
The H-2 ~ haplotype carries genes identical  to the H-2 k  genotype throughout 
most of the I  subregions of the H-2 complex. Because the latter haplotype (H- 
2 k) carries the responder allele(s),  available recombinants were examined for 
CML responsiveness.  Fig.  6 shows the CML response of various H-2  recombi- 
nant F1 mice to two doses of tumor cells. It can be seen that when 5 x  10  6 AKR 
tumor  cells  are  injected,  animals  having  only  the  H-2 k  allele(s)  in  the I-J 
subregion respond,  whereas those having the H-2 b allele(s) do not.  However, 
at  the  higher  dose of tumor  inoculation  (10  7 cells),  animals  having  the/.jb 
allele respond if high effector to target ratios are tested. These data tentatively 
map  a  locus  regulating  CML responsiveness  to  AKR tumor  cells  to  the I-J 
subregion. In light of the fact that most presently known genes associated with 1j.I 
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FIG. 6.  Cell-mediated responses of  various recombinant mice bearing the indicated H-2 
haplotype to two different  doses of  tumor cells  (numbers at  top) injected 10 days earlier.  In 
each test,  various ratios  of  effector  to target cells  were used. Incubation time was 14 h. 
the I-J subregion appear to code for antigenic determinants present on suppres- 
sor T cells (19) and soluble factors from suppressor T cells (20), such mapping 
provides  further  circumstantial  evidence for  considering  the  cell-mediated 
unresponsiveness  to  the  tumor  to  result  from  the  action  of suppressor  T 
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Discussion 
Data presented in this report, indicating that H-2 q/k and H-2 bfk hybrid mice 
fail to respond to an AKR thymoma-derived cell line, represent the first direct 
demonstration of an H-2 linked, cell-mediated immune response difference to a 
(presumed) tumor-specific transplantation antigen (TSTA). The resulting CML 
has  been  shown  to  be  specific  for  the  AKR  tumor cells  injected,  and  not 
effective against normal cells or unrelated tumor cells. It is, however, not clear 
whether the response is directed against a TSTA, a  virus-associated antigen, 
or an  antigenic change in the cell resulting from its  maintenance in tissue 
culture. This finding may be of major significance because such gene(s) have 
long been postulated in explaining the association between leukemia suscepti- 
bility and I-I-2  in mice (7,  8).  The definition of the I-J subregion is based on 
studies of Ia antigenic determinants present on suppressor T lymphocytes or 
their factors (19, 20). No Ir gene is yet assigned to this subregion. Although the 
mapping data included in this study can only be considered preliminary-it is 
based on only two experiments which included the key strain pair comparison, 
i.e.  (B10.A[5R]  x  AKR)F1 vs.  (B10.A[3R]  x  AKR)Fl-these data,  if correct, 
assign an immune suppression gene to this subregion. 
Initial studies indicate that H-2 k/k  homozygotes significantly outlive unre- 
sponsive H-2 b/k heterozygous mice after secondary and tertiary challenge with 
AKR tumor cells,  but  no  survival  difference can be  detected to  the  initial 
tumor challenge among the various hybrids. (It is important to note that most 
animals,  including responsive  F1  hybrids,  ultimately die  from the  growing 
tumor load,  even though  quantitative differences in  survival  times  can be 
detected after more than one challenge.) This result is somewhat unexpected in 
view of the fact that AKR (H-2 ~) mice show a markedly lower incidence of and 
longer survival with spontaneous Gross virus-induced leukemia than do AKR 
(H-2 k) mice (21). This may be because the experimental system used looks at a 
terminal stage of the disease,  in which the tumor level has reached greater 
than 1 ×  106 cells.  It is possible  that immune suppression genes operating at 
this late stage of the disease are considerably different from Ir genes operating 
earlier,  during  the  initial  onset  of the  disease.  Nowinski  et  al.  (22) have 
recently described genetically controlled immune responses which operate in 
the preleukemic animal, and defined such immunity as "natural immunity." 
Such genetic control is clearly distinct from the one described here. 
It will be important to understand the types of lymphocytes involved in the 
cellular responses described in the present system, as well as the interactions 
among such cells.  The present studies do not answer the question of whether a 
recessive trait coding for CML responsiveness, a dominant suppressor mecha- 
nism,  or  an  alternate mechanism is  operating in  the present experimental 
system.  Further  direct tests  to  distinguish  between these  mechanisms are 
currently in progress. 
The possibility that H-2  control of virus-induced leukemogenesis may, at 
least in some instances, result from the action of genes distinct from Ir genes 
should also be considered. Recent studies by Chesebro et al.  (23) indicate that 
resistance to FV leukemogenesis is associated with the H-2D locus of the H-2 
complex. In a series of experiments designed to test directly the role of Ir genes D.  MERUELO,  B.  DEAK,  AND  H.  O.  McDEVITT  1377 
on  FV disease,  Chesebro  et  al.  (24,  25)  found  that  little  correlation  existed 
between H-2 genotype and ability to generate either a cell-mediated or humoral 
response. Both susceptible (H-2 k) and resistant (H-2 ~) animals were capable of 
generating  vigorous  cell-mediated  and  humoral  responses.  In  addition,  H-2 
control of BT/L (4), mammary tumor virus (26),  and radiation leukemia virus 
(27) appear to be associated with the D  rather than the K  end of the complex. It 
is clear, however, that although alternative H-2-1inked mechanisms of defense 
may exist,  our understanding  of all  such mechanisms  is of major concern  in 
view of their  possible role in the  association between HLA and  a  variety of 
human neoplasms (28). 
Summary 
The  role of H-2-1inked  genes in controlling  resistance  to murine  leukemia 
viruses has been studied by measuring the cell-mediated immune response of 
F1  hybrid mice  (between AKR and  various  C3H and  C57BL/10 derived, H-2 
congenic strains) to an AKR tumor cell line, BW5147. The studies have shown 
that the ability to generate a  primary or secondary cell-mediated response to 
an  AKR tumor cell  antigenic  determinant  is under H-2  linked  control.  The 
locus determining CML responsiveness maps in the I-J subregion.  Nonrespon- 
siveness is  associated with  the H-2 qlk  and H-2 blk  hybrid genotypes,  whereas 
responsiveness is associated with the H-2 k/k homozygous genotype. Nonrespon- 
siveness may result from  (a) dominant  suppression;  (b) recessive responsive- 
ness; or  (c) an  alternate  mechanism  not yet understood.  This type of control 
may be  one  of several H-2-associated  mechanisms  of defense  against virus- 
induced neoplasms. 
The authors thank Carol Ostrem for~  her excellent technical skills  and continued interest 
throughout all  of  the studies  presented here. 
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